Lee Ainslie Qiagen N.V. Transaction History

Maverick Capital LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$43.93 - $46.76 $205,768 - $219,023	4,684 Added 52.95%	13,530 $609,000
Q1 2023 May 15, 2023	BUY	$45.29 - $50.76 $87,409 - $97,966	1,930 Added 27.91%	8,846 $406,000
Q4 2022 Feb 14, 2023	BUY	$41.91 - $50.48 $289,849 - $349,119	6,916 New	6,916 $344,000
Q4 2020 Feb 16, 2021	SELL	$46.09 - $54.74 $1.32 Million - $1.56 Million	-28,572 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$42.51 - $52.42 $59,131 - $72,916	-1,391 Reduced 4.64%	28,572 $1.49 Million
Q2 2020 Aug 14, 2020	BUY	$39.49 - $44.36 $1.18 Million - $1.33 Million	29,963 New	29,963 $1.28 Million

6.37M

Ticker QGEN
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 227,694,000
Market Cap $9.29B
Description
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...

Get notified when there are updates to the investment portfolio of Maverick Capital LTD, based on Form 13F filings with the SEC.

Stay updated on Maverick Capital LTD and Lee Ainslie with notifications on news.